$KATX
KAT EXPLORATION, INC.

2024 Q3 Form 10-Q Financial Statement

#000168316824007215 Filed on October 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2023 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $58.25K $560.00
YoY Change 10301.43% 5500.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $121.0K $560.00
YoY Change 21505.54% 5500.0%
Operating Profit -$121.0K -$560.00
YoY Change 21505.54% 5500.0%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$560.00
YoY Change 5500.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$121.0K -$560.00
YoY Change 21505.54% 5500.0%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.834B shares 1.834B shares
Diluted Shares Outstanding 1.834B shares 1.834B shares

Balance Sheet

Concept 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $40.37K $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $45.37K $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $6.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $197.7K $6.560K
YoY Change 2913.61% -62.8%
SHAREHOLDERS EQUITY
Retained Earnings -$2.871M -$2.725M
YoY Change 5.35% 1.83%
Common Stock $1.834M $1.834M
YoY Change 0.0% 2.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$152.3K -$6.560K
YoY Change
Total Liabilities & Shareholders Equity $45.37K $0.00
YoY Change

Cashflow Statement

Concept 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$121.0K -$560.00
YoY Change 21505.54% 5500.0%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1834271048 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40370 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Prepaid Rent
PrepaidRent
5000 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
5000 usd
CY2024Q3 us-gaap Assets
Assets
45370 usd
CY2023Q4 us-gaap Assets
Assets
5000 usd
CY2024Q3 KATX Due To Related Parties Current1
DueToRelatedPartiesCurrent1
182851 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
45370 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5000 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Operating Expenses
OperatingExpenses
44372 usd
us-gaap Profit Loss
ProfitLoss
-44372 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001474558
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08589
dei Entity Registrant Name
EntityRegistrantName
KAT EXPLORATION, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2737873
dei Entity Address Address Line1
EntityAddressAddressLine1
323 Sunny Isles Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Sunny Isles
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33160
dei City Area Code
CityAreaCode
561
dei Local Phone Number
LocalPhoneNumber
899-8518
CY2023Q4 KATX Due To Related Parties Current1
DueToRelatedPartiesCurrent1
10925 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
14842 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
12593 usd
CY2024Q3 us-gaap Liabilities
Liabilities
197693 usd
CY2023Q4 us-gaap Liabilities
Liabilities
23518 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1834271048 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1834271048 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1834271048 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1834271048 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1834271 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1834271 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
884054 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
884054 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2870649 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2736843 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-152324 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-18518 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
-0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
0 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
62743 usd
us-gaap Professional Fees
ProfessionalFees
68924 usd
us-gaap Professional Fees
ProfessionalFees
43510 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
58248 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
560 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64881 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
862 usd
CY2024Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2024Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2023Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2024Q3 us-gaap Depreciation
Depreciation
0 usd
CY2023Q3 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
0 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
120991 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
560 usd
us-gaap Operating Expenses
OperatingExpenses
133805 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-120991 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-560 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-133805 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-44372 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-120991 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-560 usd
us-gaap Profit Loss
ProfitLoss
-133805 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-120991 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-560 usd
us-gaap Net Income Loss
NetIncomeLoss
-133805 usd
us-gaap Net Income Loss
NetIncomeLoss
-44372 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Net Income Loss
NetIncomeLoss
-133805 usd
us-gaap Net Income Loss
NetIncomeLoss
-44372 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
174175 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-15707 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40370 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60079 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59954 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
40370 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-125 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40370 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
40000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
19954 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-56330 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-18518 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-6533 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-25051 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-6282 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-31333 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-120991 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-152324 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
19854 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-712 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
100 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-43100 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-560 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6560 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1834271048 shares
CY2024Q3 KATX Due To Related Parties Current1
DueToRelatedPartiesCurrent1
182851 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007215-index-headers.html Edgar Link pending
0001683168-24-007215-index.html Edgar Link pending
0001683168-24-007215.txt Edgar Link pending
0001683168-24-007215-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
katx-20240831.xsd Edgar Link pending
katx_ex3101.htm Edgar Link pending
katx_ex3102.htm Edgar Link pending
katx_ex3201.htm Edgar Link pending
katx_ex3202.htm Edgar Link pending
katx_i10q-083124.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
katx-20240831_cal.xml Edgar Link unprocessable
katx-20240831_def.xml Edgar Link unprocessable
katx-20240831_lab.xml Edgar Link unprocessable
katx-20240831_pre.xml Edgar Link unprocessable
katx_i10q-083124_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending